Overexpression of DARPP-32 in colorectal adenocarcinoma

International Journal of Clinical Practice

Volumn 59, Issue 1, 2005, Pages 58-61

  Wang, M S J ^a   Pan, Y ^a   Liu, N ^a   Guo, C ^a   Hong, L ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Carcinogenesis; Colorectal cancer; DARPP 32

Indexed keywords

PHOSPHOPROTEIN DARPP 32;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS;

EID: 13844317924     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2004.00305.x     Document Type: Article

References (14)

1. Greengard P. The neurobiology of slow synaptic transmission. Science 2001; 294: 1024-30
2. El-Rifai W, Smith MF Jr, Guolian Li et al. Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res 2002; 62: 4061-4.
3. Saha S, Bardelli A, Buckhaults P et al. A phosphatase associated with metastasis of colorectal cancer. Science 2001; 294: 1343-6.
4. Walaas SI, Aswad DW, Greengard P. dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 1983; 301 (5895): 69-71.
5. Hemmings HC Jr, Greengard P, Tung HY, Cohen P. DARPP32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 1984; 310: 503-5.
6. Greengard P, Allen PB, Nairn AC. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 1999; 23: 435-47.
7. Bibb JA, Snyder GL, Nishi A et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999; 402: 669-71.
8. Cohen PT. Protein phosphatase 1 - targeted in many directions. J Cell Sci 2002; 115: 241-56.
9. Shabb JB. Physiological substrates of cAMP-dependent protein kinase. Chem Rev 2001; 101 (8): 2381-411.
10. Wilson JF. Role of DARPP-32. Lancet Neurol 2002; 1 (1): 4.
11. Basu S, Dasgupta PS. Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue. Dig Dis Sci 1999; 44 (5): 916-21.
12. Carlson CC, Smithers SL, Yeh KA, Burnham LL, Dransfield DT. Protein kinase A regulatory subunits in colon cancer. Neoplasia 1999; 1 (4): 373-8.
13. Zhang J, Krishnamurthy PK, Johnson GV. Cdk5 phosphorylates p53 and regulates its activity. J Neurochem 2002; 81 (2): 307-13.
14. Takakura S, Kohno T, Manda R, Okamoto A, Tanaka T, Yokota J. Genetic alterations and expression of the protein phosphatase 1 genes in human cancers. Int J Oncol 2001; 18 (4): 817-24.